InvestorsHub Logo

MMMQA

02/29/20 10:23 AM

#827 RE: bcapps66 #826

[T]eicoplanin, oritavancin, dalbavancin, and monensin are approved antibiotics that have been shown to inhibit corona- and other viruses in the laboratory.”

– Denis Kainov
Quote:
The Company's portfolio of approved and marketed brands includes: Xydalba™ (dalbavancin hydrochloride)

LINK Oracle

02/29/20 2:25 PM

#835 RE: bcapps66 #826

I wondered the same thing at first and then found this article on rxlist.com. The name thing threw me off but once I saw this, it put CORV together with Xydalba. My question was how does Durata fit in? Do we distribute for them? Still looking but CORV looks like a great place to load up premarket Monday. Watching for the pop. AHPI was good for a 70x, I'll be happy with a 10x from here to get back to our 4s. Chart looks good, momo looks good, abnormally high volume Friday looks good and Corona spreading. I'll be adding Monday. GLTY